FIELD REFERENCE
Full criteria & treatment guidance
Indications
- SO-F-02 lists this product/category for eligible firefighting personnel in the authorized FS-ARN role. Use is limited to the indications printed on the actual container; the policy does not identify one active-ingredient formulation.
Contraindications & local exclusions
- SO-F-02 excludes known allergy to the specific medication. A complete formulation-specific contraindication list is not established for this category; identify the active ingredients and read the current product label before use.
Precautions
- The category name does not establish dose, route, age eligibility or interactions. Follow the container label and FS-ARN program restrictions. No general pediatric or 9-1-1 authority is established by this listing.
- These are selected safety checks, not a complete prescribing monograph. Product labeling and OCEMS authorization answer different questions; confirm the actual product, patient population and applicable order.
Scope & authority
- FS-ARN scope only; this listing is not a general ALS/BLS administration order.
- SO-F-02 supplies no pediatric field regimen.
Adult / adolescent
- SO-F-02 permits an authorized Fire Service RN to maintain this listed OTC product/category while functioning in the fire-service role. It is made available to firefighting personnel without a known allergy to the product.
- Use this medication only for the indications and doses printed on its container. OCEMS does not publish a universal dose for this product. Eligible personnel must obtain the medication from its container without assistance.
Pediatric
- SO-F-02 applies to adult and adolescent fire-service personnel. It does not authorize pediatric 9-1-1 dosing, and this page does not add consumer pediatric doses.
- Do not convert a package’s consumer pediatric directions into OCEMS field authority. Use an applicable pediatric standing order or medical direction for a child requiring care.
Pediatric dosing availability
- SO-F-02 supplies no pediatric 9-1-1 dosing or administration authority. This page does not add consumer pediatric doses.
| Weight | OCEMS pediatric dose |
|---|---|
| Any weight | No general OCEMS pediatric dose is listed; follow the applicable order or medical direction. |
Use, monitoring & documentation
- Identify the exact product, active ingredients, strength, and label before use; products in a named OTC category can have different formulations.
- Follow the product’s labeled indications, exclusions, dose, and interval within the authorized program. The absence of an EMS numerical dose here is intentional: SO-F-02 delegates those details to the product label.
UNDERSTAND THE CARE
Read combination ingredients before using a cough product
The program lists alcohol-free liquid or tablet preparations. Identify every active ingredient and the exact formulation before using package directions. The category does not establish a single medication, dose or complete contraindication list. The linked OCEMS document establishes the program context; a product-specific label answers a different question about the selected preparation.
Applying the guidance
The local supply listing specifies alcohol-free liquid or tablet cough preparations. Confirm that feature on the actual product and identify each active ingredient before recording what was used. A “day,” “night,” or combination-product name should not become the whole medication history. Keep the specific container directions available; this category page cannot resolve a formulation that has not been identified. SO-F-02.
Diagram text & teaching checkpoints
- Program
- Eligible FS-ARN setting and personnel.
- Identity
- Exact product, ingredients and formulation.
- Label
- Current directions, allergy and exclusions.
- Record
- Product and actual amount; no invented pediatric regimen.
Sources for this explanation
Original OCMedic teaching synthesis of the references below. Educational expansion updated ; this is not a new independent clinical-review date. Source-specific dates and limitations remain in the full guidance.